Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Non-Current Debt (2018 - 2025)

Inventiva (IVA) posted quarterly Non-Current Debt of $58.4 billion for Q2 2025, up 115678.89% year-over-year from N/an in Q2 2024, and up 12.79% quarter-over-quarter from $51.8 billion in Q4 2024.

Analysis

Inventiva (IVA) Non-Current Debt (2018 - 2025) Analysis & Trends

Inventiva's Non-Current Debt history runs 8 years deep, the most recent figure standing at $58.4 billion for Q2 2025.

  • In Q2 2025, Non-Current Debt rose 115678.89% year-over-year to $58.4 billion; the TTM figure through Jun 2025 stood at $58.4 billion (up 115678.89% YoY), while the FY2024 annual figure was $51.8 billion, up 88893.02% from the prior year.
  • Non-Current Debt for Q2 2025 stood at $58.4 billion, up from $51.8 billion in the prior quarter.
  • The five-year high for Non-Current Debt was $58.4 billion in Q2 2025, with the low at $10.1 million in Q4 2021.
  • The 5-year median for Non-Current Debt is $47.9 million (2022), against an average of $12.5 billion.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Debt soared 118026.67% in 2022, then sank 99.76% in 2023.
  • Inventiva's Non-Current Debt stood at $10.1 million in 2021, then jumped by 347.99% to $45.3 million in 2022, then gained by 28.48% to $58.2 million in 2023, then soared by 88893.02% to $51.8 billion in 2024, then advanced by 12.79% to $58.4 billion in 2025.
  • Business Quant data shows IVA's Non-Current Debt at $58.4 billion in Q2 2025, $51.8 billion in Q4 2024, and $50.4 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 882.16 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 8.96 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 546.77 Mn
10 Inventiva 893.85 Mn 893.85 Mn - 32.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 32.07 Mn
Jun 30, 2025 58.41 Mn
Dec 31, 2024 51.78 Mn
Jun 30, 2024 50.45 Mn
Dec 31, 2023 34.62 Mn
Jun 30, 2023 33.77 Mn
Dec 31, 2022 29.24 Mn
Jun 30, 2022 14.34 Mn
Dec 31, 2021 10.11 Mn
Jun 30, 2021 12.14 Mn
Mar 31, 2021 12.15 Mn
Dec 31, 2020 11.97 Mn
Dec 31, 2019 2,213.78
Dec 31, 2018 84,463.34